Morningstar's Acrux Ltd Stock Analysis
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Acrux Ltd's Company Profile
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. Its products include Testosterone Solution, Estradiol MDTS and others. It also has some of its products under the pipeline. Geographically, it has a presence in Australia; Germany; the United States, and other countries. The firm operates in a single segment and derives revenue from developing and commercialising pharmaceutical products which administer drugs topically. Substantial revenue comes from Australia and also earns revenue from overseas.
Melbourne, VIC, 3003, Australia